Cargando…
Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C
BACKGROUND & AIMS: HCV subtypes which are unusual in Europe are more prevalent in the African region, but little is known of their response to direct-acting antivirals (DAAs). These include non-1a/1b/ non-subtypeable genotype 1 (G1) or non-4a/4d (G4). In this report we aimed to describe the geno...
Autores principales: | Childs, Kate, Davis, Christopher, Cannon, Mary, Montague, Sarah, Filipe, Ana, Tong, Lily, Simmonds, Peter, Smith, Donald, Thomson, Emma C., Dusheiko, Geoff, Agarwal, Kosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057256/ https://www.ncbi.nlm.nih.gov/pubmed/31400349 http://dx.doi.org/10.1016/j.jhep.2019.07.025 |
Ejemplares similares
-
Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries
por: Mitchell, Tim, et al.
Publicado: (2022) -
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
por: Lin, Chuan-Pin, et al.
Publicado: (2021) -
SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
por: Thorlund, Kristian, et al.
Publicado: (2014) -
Towards the elimination and eradication of hepatitis B
por: Dusheiko, Geoffrey
Publicado: (2015) -
Characterisation of a Hepatitis C Virus Subtype 2a Cluster in Scottish PWID with a Suboptimal Response to Glecaprevir/Pibrentasvir Treatment
por: Shah, Rajiv, et al.
Publicado: (2022)